Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
Grandone
Elvira
E
Colaizzo
Donatella
D
Tiscia
Giovanni L
GL
Vergura
Patrizia
P
Chinni
Elena
E
Iannaccone
Luigi
L
Antinolfi
Iole
I
Guardascione
Maria A
MA
Margaglione
Maurizio
M
D000328:Adult; D016022:Case-Control Studies; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D020767:Intracranial Thrombosis / Q000139:chemically induced / Q000235:genetics; D007558:Italy; D053614:Janus Kinase 2 / Q000235:genetics*; D008641:Mesenteric Vascular Occlusion / Q000139:chemically induced / Q000235:genetics; D008642:Mesenteric Veins; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics; D011169:Portal Vein; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications / Q000235:genetics; D054556:Venous Thromboembolism / Q000139:chemically induced / Q000235:genetics; D020246:Venous Thrombosis / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics / Q000401:mortality
D003277:Contraceptives, Oral, Combined; C507924:JAK2 protein, human; D053614:Janus Kinase 2